Autopsy report · NCT00002948
High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
Cause of deathNo reason given
Life of this trial
- Registered 3 years 1 month after it had already started.
- Ran for about 7 years 3 months before it stopped.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Yale University
- Sponsor type
- University, hospital or other
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- filgrastim; topotecan hydrochloride; bone marrow ablation with stem cell support; peripheral blood stem cell transplantation
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.